ACTIVE

European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Financial year 2025 · Closed on 31/12/2025

Net result192,4 k €+326,5 %over 1 year

Gross margin280,7 k €+1 055,3 %over 1 year

Equity795,5 k €+31,9 %over 1 year

Identity

Source · BCE/KBO

European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases is a Non-profit organization incorporated in 2005. Its main activity is: Organisation of conventions and trade shows. Its registered office is in Liège.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0877.737.261
Incorporation: 06/12/2005
Legal form: Non-profit organization
Registered office: Quai Godefroid-Kurth 13
4020 Liège · WallonieSee on map
Latest accounts: 31/12/2025

Activities (NACE)

82300Organisation of conventions and trade shows· main 82300Organisation of conventions and trade shows 70200Management consultancy activities 70220Business and other management consultancy activities 94993Activities of other membership organisations n.e.c.94993Activities of other membership organisations n.e.c.

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 11 filings

Trend over 11 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	280,7 k €	+1055%	-29,4 k €	+92.3%	-381,7 k €	-2405%	-15,2 k €	-205%	14,5 k €
EBITDA	219 k €	+342%	-90,4 k €	+79.4%	-438,9 k €	-533%	-69,4 k €	-100%	-34,6 k €
Operating result	218,3 k €	+339%	-91,4 k €	+79.3%	-440,4 k €	-526%	-70,4 k €	-89.1%	-37,2 k €
Net result	192,4 k €	+326%	-84,9 k €	+81.2%	-452,3 k €	-702%	-56,4 k €	-199%	-18,9 k €
Balance sheet
Equity	795,5 k €	+31.9%	603,1 k €	-12.3%	688 k €	-39.7%	1,1 M €	-4.7%	1,2 M €
Total assets	823,7 k €	+33.1%	619 k €	-14.1%	721 k €	-39.4%	1,2 M €	-2.7%	1,2 M €
Cash	552,1 k €	+71.8%	321,3 k €	-13.7%	372,4 k €	-56.9%	864,4 k €	-21.8%	1,1 M €
Debts	28,2 k €	+76.9%	15,9 k €	+99.9%	8 k €	-68.1%	25 k €	+270%	6,7 k €
Other
Workforce	–		–		–		–		–

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

14 active · 1 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Nicholas Fuggle	Directorsince 14/04/2024
Sansin Tuzun	Directorsince 14/04/2024
Nicholas Harvey	Directorsince 06/05/2023
Nicola Veronese	Directorsince 04/04/2022
Radmila Matijevic	Directorsince 04/04/2022
Stefania Maggi	Directorsince 04/04/2022
Charlotte Beaudart	Directorsince 02/04/2020
Etienne Cavalier	Directorsince 25/03/2017
Olivier Bruyère	Managing directorsince 01/04/2014
Cyrus Cooper	Vice-chairman of the board of directorssince 24/03/2011Directorsince 24/03/2011ended
Maria-Luisa Brandi	Directorsince 03/02/2009
René Rizzoli	Directorsince 27/03/2007
Jean-Marc Kaufman	Directorsince 02/12/2005
Jean-Yves Reginster	Chairman of the board of directorssince 02/12/2005Directorsince 02/12/2005ended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
John Kanis	Director27/03/2007 → 25/03/2017

Other companies at this address

Quai Godefroid-Kurth 13 4020 Liège

Company	CBE no.
Association des Copropriétaires Résidence Bizet à Liège Quai Godefroid Kurth 13● Active	0850.237.959
BCM - ENERGIE & CONFORT● Active	0820.680.475
CENTRE ACADEMIQUE DE RECHERCHE ET D'EXPERIMENTATION EN SANTE● Active	0538.751.856
Ici ou là...● Active	0715.584.539
SaLes● Active	0803.942.037

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	04/06/2026	06/05/2025	16/05/2024	01/06/2023	03/05/2022	02/06/2021
General meeting	18/04/2026	12/04/2025	14/04/2024	06/05/2023	04/04/2022	06/04/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 11 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	18/04/2026	04/06/2026	French	PDF
Micro model	31/12/2024	12/04/2025	06/05/2025	French	PDF
Micro model	31/12/2023	14/04/2024	16/05/2024	French	PDF
Micro model	31/12/2022	06/05/2023	01/06/2023	French	PDF
Micro model	31/12/2021	04/04/2022	03/05/2022	French	PDF
Micro model	31/12/2020	06/04/2021	02/06/2021	French	PDF
Abridged model	31/12/2019	02/04/2020	26/05/2020	French	PDF
Abridged model	31/12/2018	06/04/2019	27/05/2019	French	PDF
Abridged model	31/12/2017	21/04/2018	11/06/2018	French	PDF
Abridged model	31/12/2016	25/03/2017	03/07/2017	French	PDF
Abridged model	31/12/2015	13/04/2016	07/11/2016	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

14 active · 1 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Nicholas Fuggle	Directorsince 14/04/2024
Sansin Tuzun	Directorsince 14/04/2024
Nicholas Harvey	Directorsince 06/05/2023
Nicola Veronese	Directorsince 04/04/2022
Radmila Matijevic	Directorsince 04/04/2022
Stefania Maggi	Directorsince 04/04/2022
Charlotte Beaudart	Directorsince 02/04/2020
Etienne Cavalier	Directorsince 25/03/2017
Olivier Bruyère	Managing directorsince 01/04/2014
Cyrus Cooper	Vice-chairman of the board of directorssince 24/03/2011Directorsince 24/03/2011ended
Maria-Luisa Brandi	Directorsince 03/02/2009
René Rizzoli	Directorsince 27/03/2007
Jean-Marc Kaufman	Directorsince 02/12/2005
Jean-Yves Reginster	Chairman of the board of directorssince 02/12/2005Directorsince 02/12/2005ended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
John Kanis	Director27/03/2007 → 25/03/2017

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Other30/01/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates28/06/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates08/07/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates16/06/2020
DEMISSIONS, NOMINATIONS
PDF
Mandates08/06/2017
OBJET - DEMISSIONS, NOMINATIONS
PDF
Mandates25/05/2016
DENOMINATION
PDF
Registered office15/12/2014
SIEGE SOCIAL
PDF
Mandates17/10/2014
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings11 filings

Mandates

Nicholas Fuggle

Sansin Tuzun

Nicholas Harvey

Radmila Matijevic

Nicola Veronese

Stefania Maggi

Charlotte Beaudart

Etienne Cavalier

Olivier Bruyère

Cyrus Cooper

Maria-Luisa Brandi

René Rizzoli

and 3 more mandates

2005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal DiseasesEUROPEAN SOCIETY FOR CLINICAL AND ECONOMICS ASPECTS OF OSTEOPORORIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASES

Quai Godefroid-Kurth 13, 4020 Liège-4020

Director

Managing director

Vice-chairman of the board of directors

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Quai Godefroid-Kurth 13, 4020 Liège-4020Current	accounts 2021 → 2025	Accounts 2025 · 2026-00137992

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal DiseasesCurrent	accounts 2023 → 2025	Accounts 2025 · 2026-00137992
EUROPEAN SOCIETY FOR CLINICAL AND ECONOMICS ASPECTS OF OSTEOPORORIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASES	accounts 2021 → 2022	Accounts 2022 · 2023-00107587

Events

2025
Annual accounts 2025192,4 k €↑
2024
Annual accounts 2024-84,9 k €↑
2023
Annual accounts 2023-452,3 k €↓
2023
Name changeEuropean Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
2022
Annual accounts 2022-56,4 k €↓
2021
Annual accounts 2021-18,9 k €↓
2020
Annual accounts 2020184,3 k €↑
2019
Annual accounts 2019-72,6 k €↓
2018
Annual accounts 2018207,1 k €↑
2017
Annual accounts 2017-529,7 k €↓
2016
Annual accounts 2016-91,8 k €↓
2015
Annual accounts 2015294,9 k €
06/12/2005
IncorporationNon-profit organization

European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events